New AI method to pick up arthritis, lupus early in high-risk patients

IANS January 8, 2025 193 views

Researchers have developed an exciting new AI method that can predict the progression of autoimmune diseases like rheumatoid arthritis and lupus before they fully develop. The technique, called Genetic Progression Score (GPS), is significantly more accurate than previous models in identifying early symptoms. By analyzing preclinical indicators, doctors can now potentially intervene earlier and create more personalized treatment plans. This breakthrough could dramatically improve patient outcomes by catching these complex diseases in their earliest stages.

"By targeting a more relevant population, we can use machine learning to identify patients with the highest risk for disease" - Dajiang Liu, Penn State College of Medicine
New AI method to pick up arthritis, lupus early in high-risk patients
New Delhi, Jan 8: Artificial intelligence (AI) can significantly aid in early detection of autoimmune diseases, like rheumatoid arthritis and lupus especially in high-risk patients, leading to better outcomes, finds a study.

Key Points

1

AI-powered Genetic Progression Score identifies early autoimmune disease markers

2

Machine learning analyzes preclinical symptoms with unprecedented accuracy

3

New method enables personalized intervention strategies

4

Improves potential for early treatment and disease management

In people with autoimmune diseases, the immune system mistakenly attacks their body's healthy cells and tissues. Some well-known diseases include type 1 diabetes, multiple sclerosis, lupus, and rheumatoid arthritis.

Early diagnosis is critical and may improve treatment and better disease management, said the team led by researchers from the Penn State College of Medicine.

Using machine learning, a type of AI, the team developed a new method that could predict the progression of autoimmune disease among people with preclinical symptoms.

These diseases often include a preclinical stage before diagnosis that's characterised by mild symptoms or certain antibodies in the blood.

The method dubbed Genetic Progression Score or GPS, could predict the progression from preclinical to disease stages.

In the study, the team used GPS to analyse real-world data to predict the progression of rheumatoid arthritis and lupus.

Compared to existing models, this methodology was found between 25 and 1,000 per cent more accurate in determining mild symptoms that would move to advanced disease stage, the findings showed.

"By targeting a more relevant population -- people with a family history or who are experiencing early symptoms -- we can use machine learning to identify patients with the highest risk for disease," said Dajiang Liu, Professor, at the Penn State College of Medicine. Liu noted that this can also help "identify suitable therapeutics that may be able to slow down the progression of the disease".

Accurate prediction of disease progression using GPS can enable early interventions, targeted monitoring, and personalised treatment decisions, leading to improved patient outcomes, Liu said.

Tags:
You May Like!